```html

Akers Biosciences (AKER) and Google Finance

Akers Biosciences, Inc. (AKER) is a biotechnology company focused on developing, manufacturing, and supplying rapid diagnostic tests and medical devices designed to provide healthcare professionals with cost-effective information quickly and easily. Understanding Akers' financial performance is crucial for investors and industry analysts, and Google Finance is a commonly used tool for tracking this.

Akers Biosciences' Focus: Akers primarily concentrates on point-of-care testing (POCT), which allows diagnostic tests to be performed near the patient, yielding faster results compared to traditional laboratory testing. Their product portfolio has included tests for heparin-induced thrombocytopenia (HIT), a dangerous drug-induced allergy; allergies; and breath alcohol detection. In the past, their flagship product, the PIFA Heparin PF4 Rapid Assay, was a significant revenue driver. However, the company has faced challenges and shifts in strategy over time, impacting its financial standing.

Akers Biosciences on Google Finance: Google Finance provides a snapshot of Akers Biosciences' stock performance. Key information typically available includes:

• Real-time Stock Price: The current trading price of AKER shares.
• Daily Price Fluctuations: The high, low, open, and closing prices for the day, as well as the trading volume.
• Historical Data: Charts displaying the stock's performance over various time periods (e.g., one day, one week, one month, one year, five years, or the maximum available period). This allows users to analyze trends and patterns.
• Key Statistics: Essential financial metrics such as market capitalization, price-to-earnings (P/E) ratio (if applicable, given Akers' historical profitability challenges), earnings per share (EPS), dividend yield (typically not applicable for Akers), and beta.
• News and Related Articles: Links to news articles and press releases related to Akers Biosciences, offering insights into company announcements, industry trends, and analyst opinions.
• Financial Statements: Access to Akers' income statements, balance sheets, and cash flow statements, enabling deeper analysis of the company's financial health.

Using Google Finance for Akers Biosciences: Investors use Google Finance to monitor AKER's stock price movements and assess its investment potential. The historical data is valuable for technical analysis, identifying potential support and resistance levels, and evaluating long-term trends. The news section provides timely updates on company performance and significant events. The availability of financial statements allows for fundamental analysis, assessing the company's revenue, expenses, assets, liabilities, and cash flow.

Caveats and Considerations: While Google Finance is a useful tool, it's essential to acknowledge its limitations. The information provided is a summary and should not be the sole basis for investment decisions. Investors should conduct thorough due diligence, including reviewing Akers Biosciences' SEC filings (e.g., 10-K and 10-Q reports), analyzing industry trends, and considering the company's competitive landscape. Akers has experienced volatility and strategic shifts, so a comprehensive understanding is critical before investing. Furthermore, real-time data may have slight delays compared to direct market feeds.

In conclusion, Google Finance offers a convenient platform to track Akers Biosciences' stock performance and access relevant financial information. However, responsible investing requires supplementing this information with in-depth research and professional financial advice.

```